Data / Form D filings / Beta Cat Pharmaceuticals, Inc.
Beta Cat Pharmaceuticals, Inc.: Form D filings
Beta Cat Pharmaceuticals, Inc., a pharmaceuticals company in Houston, TX, filed 4 Form D notices with the SEC between 2014 and 2018. The latest, on June 27, 2018, reports $2.6 million sold of a $6 million offering to 3 investors.
Find out what Beta Cat Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2450 WEST HOLCOMBE BLVD, Houston, TX, 77021
- Phone
- (317) 517-9500
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2014
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1612655
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 27, 2018 | New notice | $6,000,000 | $2,600,000 | $3,400,000 | 3 | Jun 12, 2018 | sec.gov |
| Dec 18, 2017 | New notice | $1,404,918 | $1,404,918 | $0 | 17 | Jul 25, 2016 | sec.gov |
| Jul 2, 2015 | New notice | $3,035,583 | $1,039,561 | $1,996,022 | 2 | Jun 18, 2015 | sec.gov |
| Jul 8, 2014 | New notice | $500,000 | $500,000 | $0 | 1 | Jun 19, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jonathan Northrup | Director | |
| James Eadie | Director | |
| Rahul Aras | Executive Officer | |
| Kenneth Carter | Director | |
| Joe Cunningham | Director | |
| Uma Bhatt | Executive Officer |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
Every Form D from the week of Jun 25, 2018 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Beta Cat Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.